| | | |   | | | | By Rachel Cohrs Mike Reddy for STAT The once-invincible organization PhRMA used to raise hell. Lately, however, the lobbying group's rhetoric is on mute. Read More | | By Lev Facher Adobe A heavyweight in addiction policy blasts the FDA's opioid mail-back proposal, while endorsing a funder's drug-disposal product. Read More | | By Vineeta Gupta Adobe The World Bank has rolled out The Pandemic Fund, a new financial intermediary fund, on an improbable and harmful timetable. Read More | | Sponsored Insight by Viiv Healthcare How HCPs can guide the next decade of HIV PrEP Significant progress has been made in HIV prevention since the first HIV PrEP medicine was approved a decade ago, yet PrEP remains underutilized. But now HCPs have the opportunity to offer options that can meet patients' unique needs. Having an honest dialogue about the importance of sexual health and PrEP with all our patients, especially those most disproportionately impacted with HIV, is the first step. Read more here. | | By Megan Molteni Kin Cheung/AP He Jiankui posted photos of himself sitting at a computer in a white office. "This is the first day for Jiankui He Lab," he wrote. Read More | |
No comments